To date, ERS associated UPR has attracted much attention from researchers and oncologists, as it could influence tumor proliferation and aggravation, and determine cell fate via three pathway branches initiated by IRE1α, PERK, and ATF6 (Urra et al., 2016; Oakes, 2020). This evidence concerns the gene ATF6 and neoplasm.